After reading the articles by Le Cook et al. (2017) and Ninnemann (2012), discuss the following points:
What differences/concerns are noted with regard to psychotropic use with Black, Latino, and White youth?
What are pharmacogenomics and ethnopsychopharmacology, and what are their relevance to prescribing psychology? Be specific.
What differences/concerns are noted with regard to psychotropic use with Black, Latino, and White youth?
